Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Vomiting 5 Nausea 4 Neoplasms 3 Lymphoma 2 Solid Tumors 1 Prostatic Neoplasms 1 Polyps 1 Mouth Neoplasms 1 Metastatic Neuroendocrine Prostate Cancer 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Intestinal Obstruction 1 Hypopharyngeal Neoplasms 1 Critical Illness 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 15 atezolizumab 11 Gemcitabine 11 Carboplatin 9 pembrolizumab 8 Docetaxel 8 Irinotecan 7 Bevacizumab 7 Injections 6 Cetuximab 6 Sunitinib 5 Leucovorin 5 Fluorouracil 5 Cyclophosphamide 5 Capecitabine 5 tocilizumab 4 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 temsirolimus 3 spartalizumab 3 pazopanib 3 lenvatinib 3 fludarabine 3 cobimetinib 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumors × Metoclopramide × Clear all

NCT02135510 2020-03-31

MEDEA

Amsterdam UMC, location VUmc

Phase 3 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡